Evidence map›Paper›PMID 28759377›Full record

ArticleThe Lancet. Oncology2017

Evidence-based management of adult patients with diffuse glioma - Authors' reply.

Michael Weller, Martin van den Bent, Jörg C Tonn, Roger Stupp, Matthias Preusser, Elizabeth Cohen-Jonathan-Moyal, Roger Henriksson, Emilie Le Rhun, Carmen Balana, Olivier Chinot and 16 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The Lancet. Oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Michael WellerDepartment of Neurology, Brain Tumour Centre, University Hospital and University of Zurich, CH-8091 Zurich, Switzerland. Electronic address: michael.weller@usz.ch.
Martin van den BentNeurooncology Unit, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
Jörg C TonnDepartment of Neurosurgery, Ludwig-Maximilians-University Munich, Munich, Germany.
Roger StuppDepartment of Oncology, Brain Tumour Centre, University Hospital and University of Zurich, CH-8091 Zurich, Switzerland.
Matthias PreusserDepartment of Medicine, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna, Austria.
Elizabeth Cohen-Jonathan-MoyalDépartement de Radiotherapie, Institut Claudius Regaud, L'Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
Roger HenrikssonRegional Cancer Centre Stockholm-Gotland and Department of Radiation Sciences and Oncology, Umeå University Hospital, Umeå, Sweden.
Emilie Le RhunNeuro-Oncology, Department of Neurosurgery, University Hospital, Lille, France.
Carmen BalanaCatalan Institute of Oncology, Hospital Germans Trias i Pujol, Barcelona, Spain.
Olivier ChinotDepartment of Neuro-Oncology, Aix-Marseille Université, Assistance Publique-Hopitaux de Marseille, Centre Hospitalo-Universitaire Timone, Marseilles, France.
Martin BendszusDepartment of Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany.
Jaap C ReijneveldDepartment of Neurology and Brain Tumour Centre Amsterdam, Vrije Universiteit Medical Centre, Amsterdam, Netherlands.
Frederic DhermainDepartment of Radiotherapy, Gustave Roussy University Hospital, Villejuif, France.
Pim FrenchDepartment of Neurology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
Christine MarosiDepartment of Medicine, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna, Austria.
Colin WattsDepartment of Clinical Neurosciences, Division of Neurosurgery, University of Cambridge, Cambridge, UK.
Ingela ObergDivision of Neurosurgery, Addenbrooke's Hospital, Cambridge University Hospitals Foundation Trust, Cambridge, UK.
Geoffrey PilkingtonBrain Tumour Research Centre, University of Portsmouth, Portsmouth, UK.
Brigitta G BaumertDepartment of Radiation Oncology, MediClin Robert Janker Clinic and Clinical Cooperation Unit Neurooncology, University of Bonn Medical Centre, Bonn, Germany.
Martin J B TaphoornDepartment of Neurology, Leiden University Medical Centre and Medical Centre Haaglanden, The Hague, Netherlands.
Monika HegiDepartment of Clinical Neurosciences, University Hospital Lausanne, Lausanne, Switzerland.
Manfred WestphalDepartment of Neurosurgery, University Hospital Hamburg, Hamburg, Germany.
Guido ReifenbergerDepartment of Neuropathology, Heinrich Heine University Düsseldorf and German Cancer Consortium, Essen/Düsseldorf, Germany.
Riccardo SoffiettiDepartment of Neuro-Oncology, University Hospital, Turin, Italy.
Wolfgang WickNeurology Clinic and National Centre for Tumour Diseases, University Hospital Heidelberg, Heidelberg, Germany; German Consortium of Translational Cancer Research, Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany.
European Association for Neuro-Oncology (EANO) Task Force on Gliomas

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Brain NeoplasmsGliomaAdultHumans

Identifiers

PMID28759377

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.